x € million |
|
Share capital |
|
Share premium |
|
Treasury shares |
|
Other reserves |
|
Retained earnings |
|
Shareholders’ equity |
|
Non-controlling interests |
|
Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at 1 January 2022 |
|
328 |
|
471 |
|
(177) |
|
156 |
|
8,540 |
|
9,318 |
|
79 |
|
9,397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
- |
|
- |
|
- |
|
230 |
|
1,700 |
|
1,930 |
|
12 |
|
1,942 |
Dividend |
|
- |
|
- |
|
- |
|
- |
|
(459) |
|
(459) |
|
- |
|
(459) |
Options/performance shares granted |
|
- |
|
- |
|
- |
|
34 |
|
- |
|
34 |
|
- |
|
34 |
Options/performance shares vested/canceled |
|
- |
|
- |
|
- |
|
(29) |
|
29 |
|
- |
|
- |
|
- |
Repurchase of shares |
|
- |
|
- |
|
(210) |
|
- |
|
- |
|
(210) |
|
- |
|
(210) |
Reissued shares |
|
- |
|
- |
|
191 |
|
- |
|
(50) |
|
141 |
|
- |
|
141 |
Acquisition (divestment) of subsidiary with NCI |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(4) |
|
(4) |
Transfer |
|
- |
|
- |
|
- |
|
(28) |
|
17 |
|
(11) |
|
11 |
|
- |
Other changes |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
4 |
|
4 |
Balance at 31 December 2022 |
|
328 |
|
471 |
|
(196) |
|
363 |
|
9,777 |
|
10,743 |
|
102 |
|
10,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
- |
|
- |
|
- |
|
116 |
|
2,060 |
|
2,176 |
|
7 |
|
2,183 |
Dividend |
|
- |
|
(425) |
|
- |
|
- |
|
(157) |
|
(582) |
|
- |
|
(582) |
Options/performance shares granted |
|
- |
|
- |
|
- |
|
23 |
|
- |
|
23 |
|
- |
|
23 |
Options/performance shares vested/canceled |
|
- |
|
- |
|
- |
|
(23) |
|
23 |
|
- |
|
- |
|
- |
Reissued shares |
|
- |
|
- |
|
63 |
|
- |
|
(39) |
|
24 |
|
- |
|
24 |
Repurchase of shares |
|
- |
|
- |
|
(256) |
|
- |
|
- |
|
(256) |
|
- |
|
(256) |
Cancellation of shares |
|
(67) |
|
(2) |
|
345 |
|
- |
|
(276) |
|
- |
|
- |
|
- |
Liability to non-tendered shareholders DSM N.V. |
|
(10) |
|
(42) |
|
- |
|
- |
|
(597) |
|
(649) |
|
- |
|
(649) |
Issued new shares (including swap DSM N.V. into DSM-Firmenich AG) |
|
(248) |
|
11,758 |
|
- |
|
- |
|
- |
|
11,510 |
|
- |
|
11,510 |
Expenditures issuance new shares |
|
- |
|
(29) |
|
- |
|
- |
|
- |
|
(29) |
|
- |
|
(29) |
Acquisition of subsidiary with NCI |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
48 |
|
48 |
Divestment of subsidiary with NCI |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(4) |
|
(4) |
Remuneration on deeply subordinated fixed rate resettable perpetual notes |
|
- |
|
- |
|
- |
|
- |
|
(28) |
|
(28) |
|
- |
|
(28) |
Transfer |
|
- |
|
- |
|
- |
|
(5) |
|
(4) |
|
(9) |
|
9 |
|
- |
Other changes |
|
- |
|
- |
|
- |
|
- |
|
(15) |
|
(15) |
|
- |
|
(15) |
Balance at 31 December 2023 |
|
3 |
|
11,731 |
|
(44) |
|
474 |
|
10,744 |
|
22,908 |
|
162 |
|
23,070 |
